These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18024904)

  • 21. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity.
    Hesselgesser J; Liang M; Hoxie J; Greenberg M; Brass LF; Orsini MJ; Taub D; Horuk R
    J Immunol; 1998 Jan; 160(2):877-83. PubMed ID: 9551924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.
    Xiang J; McLinden JH; Kaufman TM; Mohr EL; Bhattarai N; Chang Q; Stapleton JT
    Virology; 2012 Aug; 430(1):53-62. PubMed ID: 22608061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy.
    Alcalde R; Nishiya A; Casseb J; Inocêncio L; Fonseca LA; Duarte AJ
    Virus Res; 2010 Aug; 151(2):148-52. PubMed ID: 20420864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
    Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1beta correlates with down-modulation of CXCR4.
    Yang OO; Swanberg SL; Lu Z; Dziejman M; McCoy J; Luster AD; Walker BD; Herrmann SH
    J Virol; 1999 Jun; 73(6):4582-9. PubMed ID: 10233917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.
    Crotti A; Neri F; Corti D; Ghezzi S; Heltai S; Baur A; Poli G; Santagostino E; Vicenzi E
    J Virol; 2006 Nov; 80(21):10663-74. PubMed ID: 16943296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
    Nokta MA; Li XD; Nichols J; Mallen M; Pou A; Asmuth D; Pollard RB
    AIDS; 2001 Jan; 15(2):161-9. PubMed ID: 11216923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.
    BouHamdan M; Strayer DS; Wei D; Mukhtar M; Duan LX; Hoxie J; Pomerantz RJ
    Gene Ther; 2001 Mar; 8(5):408-18. PubMed ID: 11313818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.
    Soriano A; Martínez C; García F; Plana M; Palou E; Lejeune M; Aróstegui JI; De Lazzari E; Rodriguez C; Barrasa A; Lorenzo JI; Alcamí J; del Romero J; Miró JM; Gatell JM; Gallart T
    J Infect Dis; 2002 Oct; 186(7):922-31. PubMed ID: 12232832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4.
    Naif HM; Cunningham AL; Alali M; Li S; Nasr N; Buhler MM; Schols D; de Clercq E; Stewart G
    J Virol; 2002 Apr; 76(7):3114-24. PubMed ID: 11884536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some mechanisms of FLIP expression in inhibition of HIV-1 replication in Jurkat cells, CD4+ T cells and PBMCs.
    Tan J; Wang X; Devadas K; Zhao J; Zhang P; Hewlett I
    J Cell Physiol; 2013 Dec; 228(12):2305-13. PubMed ID: 23696271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV entry inhibition by the envelope 2 glycoprotein of GB virus C.
    Jung S; Eichenmüller M; Donhauser N; Neipel F; Engel AM; Hess G; Fleckenstein B; Reil H
    AIDS; 2007 Mar; 21(5):645-7. PubMed ID: 17314528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
    Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
    J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of CXCR-4 and CCR-5 expression by interferon-gamma is associated with inhibition of chemotaxis and human immunodeficiency virus (HIV) replication but not HIV entry into human monocytes.
    Creery D; Weiss W; Lim WT; Aziz Z; Angel JB; Kumar A
    Clin Exp Immunol; 2004 Jul; 137(1):156-65. PubMed ID: 15196257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway.
    Popik W; Hesselgesser JE; Pitha PM
    J Virol; 1998 Aug; 72(8):6406-13. PubMed ID: 9658081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
    Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
    J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
    Schols D; Esté JA; Cabrera C; De Clercq E
    J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.